Prospect Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,667
Closed -$229K 119
2024
Q4
$229K Buy
2,667
+965
+57% +$104K 0.13% 101
2024
Q3
$203K Sell
1,702
-200
-11% -$26.7K 0.13% 101
2024
Q2
$271K Sell
1,902
-453
-19% -$60K 0.21% 63
2024
Q1
$302K Buy
2,355
+13
+0.6% +$1.55K 0.25% 59
2023
Q4
$242K Buy
+2,342
New +$232K 0.24% 61

Other funds holding NVO

Prospect Financial Services's NVO Position: Q1 2025 in Review

Prospect Financial Services sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,667 shares — an estimated $229K sold.

Prospect Financial Services first reported a position in NVO in Q4 2023 and held it in 5 quarters. The position peaked at $302K in Q1 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Prospect Financial Services reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Prospect Financial Services sold 2,667 Novo Nordisk shares in Q1 2025, an estimated $229K.
  • Prospect Financial Services first reported a position in Novo Nordisk in Q4 2023 and held it in 5 quarters.
  • Prospect Financial Services's Novo Nordisk position peaked at $302K in Q1 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Prospect Financial Services's 13F filing for Q1 2025, filed 11 Apr 2025.